Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance.

ElTanbouly MA, Zhao Y, Nowak E, Li J, Schaafsma E, Le Mercier I, Ceeraz S, Lines JL, Peng C, Carriere C, Huang X, Day M, Koehn B, Lee SW, Silva Morales M, Hogquist KA, Jameson SC, Mueller D, Rothstein J, Blazar BR, Cheng C, Noelle RJ.

Science. 2020 Jan 17;367(6475). pii: eaay0524. doi: 10.1126/science.aay0524.

PMID:
31949051
2.

VISTA: Coming of age as a multi-lineage immune checkpoint.

ElTanbouly MA, Schaafsma E, Noelle RJ, Lines JL.

Clin Exp Immunol. 2020 Jan 13. doi: 10.1111/cei.13415. [Epub ahead of print] Review.

PMID:
31930484
3.

Defining the Signature of VISTA on Myeloid Cell Chemokine Responsiveness.

Broughton TWK, ElTanbouly MA, Schaafsma E, Deng J, Sarde A, Croteau W, Li J, Nowak EC, Mabaera R, Smits NC, Kuta A, Noelle RJ, Lines JL.

Front Immunol. 2019 Nov 19;10:2641. doi: 10.3389/fimmu.2019.02641. eCollection 2019.

4.

VISTA: a novel immunotherapy target for normalizing innate and adaptive immunity.

ElTanbouly MA, Croteau W, Noelle RJ, Lines JL.

Semin Immunol. 2019 Apr;42:101308. doi: 10.1016/j.smim.2019.101308. Review.

PMID:
31604531

Supplemental Content

Loading ...
Support Center